BNTX
BioNTech SE
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 3 | 6/26/2026 | View on SEC |
| 3 | 6/26/2026 | View on SEC |
| 6-K | 6/8/2026 | View on SEC |
| 6-K | 6/1/2026 | View on SEC |
| 6-K | 5/22/2026 | View on SEC |
| 6-K | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/14/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BNTX |
| Company Name | BioNTech SE |
| CIK | 1776985 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | 2M |
| Phone | 0049613190840 |